(Q33858074)

English

Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity (English)

1 reference

Europe PubMed Central

29 July 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Oleandri SE

1

1 reference

Europe PubMed Central

29 July 2017

Maccario M

2

1 reference

Europe PubMed Central

29 July 2017

Rossetto R

3

1 reference

Europe PubMed Central

29 July 2017

Procopio M

4

1 reference

Europe PubMed Central

29 July 2017

Grottoli S

5

1 reference

Europe PubMed Central

29 July 2017

Avogadri E

6

1 reference

Europe PubMed Central

29 July 2017

Gauna C

7

1 reference

Europe PubMed Central

29 July 2017

Ganzaroli C

8

1 reference

Europe PubMed Central

29 July 2017

Ghigo E

9

1 reference

Europe PubMed Central

29 July 2017

publication date

1 February 1999

1 reference

Europe PubMed Central

29 July 2017

Journal of Endocrinological Investigation

1 reference

Europe PubMed Central

29 July 2017

22

1 reference

Europe PubMed Central

29 July 2017

2

1 reference

Europe PubMed Central

29 July 2017

134-140

1 reference

Europe PubMed Central

29 July 2017

https://scigraph.springernature.com/pub.10.1007/bf03350893

0 references

Clinical review 26: Insulin resistance in obese and nonobese man.

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

International trial of long-term dexfenfluramine in obesity.

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

Effects of metformin in obese patients with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

Biguanides and NIDDM

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

Metformin and intestinal glucose handling

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women.

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine.

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man.

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

The endocrinology of obesity

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men.

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

Fenfluramine increases insulin action in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

Reduced testosterone and adrenal C19 steroid levels in obese men.

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity.

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

Relations between immunoreactive somatomedin C, insulin and T3 patterns during fasting in obese subjects

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

Insulin and growth hormone act synergistically to stimulate insulin-like growth factor-I production by cultured chicken hepatocytes

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

6 Factors controlling blood concentration of somatomedin C

1 reference

https://api.crossref.org/works/10.1007%2FBF03350893

21 January 2018

Health implications of obesity. National Institutes of Health Consensus Development Conference Statement

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin inhibits adrenal 17,20-lyase activity in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin effects on peripheral sensitivity to insulin in non diabetic obese subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of obesity on the response to acute adrenocorticotropin stimulation in eumenorrheic women

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of serotonergic neurotransmission on pituitary hormone release in obese and non-obese females.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of fenfluramine on episodic ACTH and cortisol secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin and free fatty acid metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obesity and metabolic complications: contribution of dehydroepiandrosterone and other steroid hormones.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin in noninsulin-dependent diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical studies with d-fenfluramine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anorectic effect of metformin in obese Zucker rats: lack of evidence for the involvement of neuropeptide Y

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of metformin on various aspects of glucose, insulin and lipid metabolism in patients with non-insulin-dependent diabetes mellitus with varying degrees of hyperglycemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin and the biology of feeding

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine and metabolic effects of dexfenfluramine in patients with android obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired growth hormone response to insulin-induced hypoglycaemia in obese patients: restoration blocked by ritanserin after fenfluramine administration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between insulin-like growth factor-I, adiposity, and aging

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of hypocaloric diet with and without D-fenfluramine treatment on growth hormone release after growth hormone-releasing factor stimulation in patients with android obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fenfluramine in the treatment of non-insulin-dependent diabetics: hypoglycemic versus anorectic effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of a reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulfate in nondiabetic men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dexfenfluramine reduces cardiovascular risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10195381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF03350893

1 reference

Europe PubMed Central

29 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33858074&oldid=1534064192"